Animal testing is crucial for measuring the efficacy and safety of new treatments. It is also a step that everyone would like to avoid as much as possible for economic, regulatory, and ethical reasons. But what are the alternatives, and can they really reduce the use of animals in drug development? Before drug developers let […]
This week’s guest is Joseph Ferner of Inpart, the author of a new R&D Trends Report on Immunology and Inflammation. Together we discussed the research landscape
Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […]